MNKD
MannKind Corp
NASDAQ: MNKD · HEALTHCARE · BIOTECHNOLOGY
$2.75
-1.43% today
Updated 2026-04-29
Market cap
$849.19M
P/E ratio
137.50
P/S ratio
2.43x
EPS (TTM)
$0.02
Dividend yield
—
52W range
$2 – $7
Volume
6.3M
MannKind Corp (MNKD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |